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IMPROVEMENT IN 
FUNCTIONAL RECOVERY 
OF THE ISOLATED 
GUINEA PIG HEART 
AFTER HYPERKALEMIC 
REPERFUSION WITH 
ADENOSINE 
The aim of this study was to examine the ffect of initial hyperkalemic 
reperfusion (HKR), with and without added adenosine, on eoronary flow, 
myoeardial function, and endothelium-dependent andendothelium-indepen- 
dent coronary vaseular funetion. Cardioplegic arrest was indueed in 40 
isolated guinea pig hearts by infusing oxygenated cardioplegic (high in 
potassium ion) Krebs solution for 5 minutes. Hearts were then stored at room 
temperature for 3.5 hours. On reperfusion, hearts were divided into four 
groups of 10 hearts eaeh: eontrol, reperfusion with regular Krebs solution (4.6 
mmol/L potassium chloride); base hyperkalemic reperfusion, initial reperfu- 
sion with 37 ° C oxygenated, eardioplegic Krebs solution for 5 minutes; 
hyperkalemic reperfusion withaddition of 1 mmol/L adenosine during HKR; 
and hyperkalemic reperfusi0n with addition of 5 mmol/L adenosine. Coronary 
reserve (adenosine bolus 2 mmol/L) and responses to acetylcholine (1/~moi/L) 
and nitroprusside (100/~m01/L) were examined before and after ischemia nd 
reperfusion. Flow did not return to preischemic values in any group after 
reperfusion. Adenosine treatment during initiai reperfusion increased coro- 
nary flow (pereentage of baseline -+ standard error of the mean) from 57% -+ 
4% in control and 45% - 3% in hearts with hyperkalemic reperfusion to 79% +- 
3% and 83% - 5% in hearts with hyperkalemic reperfusion also treated with, 
respectively, 1 mmol/L adenosine and 5 mmol/L adenosine (p < 0.05). At 30 
and 60 lninutes of reperfusion, however, flow remained elevated only in the 
group treated with 5 mmol/L adenosine. Coronary reserve and responses to 
acetylcholine and nitroprusside were equivalently depressed in all groups after 
reperfusion. Recovery of left ventricular systolic and diastolic function was 
improved in all groups after hyperkalemic reperfusion (54% - 4% of preisch- 
emic value) compared with control (39% -+ 3%), and recovery was further 
enhanced in the group treated with 5 mmol/L adenosine (60% +- 4%). In this 
ex vivo model, hyperkalemic reperfusion improved myocardial function after 
cardioplegic arrest and the addition of 5 mmoFL adenosine improved coronary 
flow. Adenòsine may c0unteract he potassium chloride-induced vasoconstric- 
tion that occurs during hyperkalemic reperfusion and may thus improve 
coronary flow and myocardial function. Postischemic depression of endotheli- 
um-dependent or endothelium-independent vascular functions, however, was 
not alleviated by hyperkalemic reperfusion with or without adenosine. 
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W arm cardioplegic blood reperfusion was long ago demonstrated to reduce reperfusion dam- 
age in a canine model of ischemia and reperfu- 
sion.1, 2 It was found that by lowering calcium and 
increasing pH, potassium, and osmolarity in the 
initial 500 ml of blood reperfusate, left ventricularp- 
erformance as measured by left ventricular pressure 
and maximum pressure changes (dp/dt ... .  ), which 
was depressed by about 40% in control hearts, could 
be nearly restored. Arresting the heart was thought 
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to reduce oB,gen demand during this initial reper- 
fusion period, making the delivered oxygen available 
for reparative work and replenishment of energy 
stores before the onset of cardiac pump function. A 
whole series of consecutive xperimental studies, 
aimed at further improving the method, corrobo- 
rated the beneficial effects of warm cardioplegic 
blood reperfusion, 3-7 which seemed to be effective in 
human beings as well as in animals, s' 9 
Although the benefits of hyperkalemic reperfu- 
sion (HKR) for recovery of myocardial function are 
well documented, ata concerning coronary vascular 
function are less conclusive. Potassium is a well 
known vasoconstrictor and is regularly used in iso- 
lated vessei preparations to constrict vessel rings. A 
high potassium concentration reduces myocardial 
oxygen demand by reducing cardiac work, but it also 
limits oxygen delivery by restricting coronary flow so 
that this ratio is reducedJ ° Flow during HKR was 
not reported in Follette and colleagues' initial 
study, 2 and oxygen supply, as well as demand, may 
decrease during HKR. Regional blood flow was 
measured in the beating working heart before and 
after ischemia and reperfusion, however, and a 
marked decrease (almost 25%) in coronary flow was 
observed in the group receiving only the high- 
potassium reperfusate. 2 In human beings, coronary 
flow during HKR was found to either decrease s or 
increase, 9 possibly depending on previous damage 
to the coronary vasculature. Moreover, the effect of 
metabolical!y mediated flow changes could not be 
determined because coronary sinus oxygen was not 
measured, fn this study, we investigated the effect of 
HKR on coronary flow and myocardial oxygen 
balance in an ex vivo model of cardiac ischemia and 
reperfusionl The isolated, Langendorff-perfused 
guinea pig heart preparation allows careful control 
of extrinsic variables and precise on-line measure- 
ment of global coronary flow and oxygen extraction 
during all phases of the experiment. The prepara- 
tion is also suitable for testing endothelium-depen- 
dent and endothelium-independent vascular espon- 
siveness and release of metabolic byproducts. Our 
aim was to irnprove recovery of myocardial function 
by augmenting coronary flow during HKR through 
the addition of the coronary vasodilator adenosine 
to the initiai cardioplegic reperfusate. An improve- 
ment in the o~¢gen utrient supply caused by aden- 
osine, coup!ed with depression of contractility by 
high potassium during HKR, might result in im- 
proved cardiac performance after ischemia. 
Methods 
After Animal Studies Committee approval was ob- 
tained, 40 albino English short-haired guinea pigs (250 to 
350 gm) were injected intraperitoneally with 20 mg ket- 
amine and 1000 U heparin. The animals were decapitated 
when unresponsiye to noxious timuli. All animals re- 
ceived humane care in compliance with the "Principles of 
Laboratory Animal Care" formulated by the National 
Society for Medical Research and the "Guide for the Care 
and Use of Laboratory Animals" published by the Na- 
tional Institutes of Health. Our methods have been pub- 
lished in detail. 1°'I2 After thoracotomy, the aorta was 
cannulated istal to the aortic valve and the venae cavae 
and pulmonary artery were cut. Each heart was immedi- 
ately perfused retrogradely through the aorta and excised. 
All hearts were perfused at a controlled perfusion pres- 
sure of 55 mm Hg, as measured at the aortic root. The 
perfusate, a modified Krebs-Ringer solution, was filtered 
in line (5/xm pore size, Astrodisc; Gelman Scientific, Ann 
Arbor, Mich.) and contained the following: 137 mmol/L 
sodium ion, 4.5 mmol/L potassium ion, 1.2 mmol/L mag- 
nesium ion, 2.5 mmol/L calcium ion, 134 mmol/L chloride 
ion, 15.5 mmol/L bicarbonate, 1.2 mmol/L dihydrogen 
phosphate, 11.5 mmol/L glucose, 2 mmol/L pyruvate, 16 
mmol/L mannitol, 0.05 mmol/L ethylenediaminetetraace- 
tic acid, and 5 U/L insulin. Cardioplegic Krebs solution 
has an equivalent osmolarity, 300 mosm/L, but differs in 
concentrations of sodium ion (123 mmol/L), potassium 
ion (28 mmol/L), and calcium ion (1.25 mmol/L). Perfu- 
sate and bath temperatures were maintained at 37 ° C by 
means of a thermostatically controlled watet circulator 
(VWR 1130; Preston Industries Inc., Niles, Ill.). Both 
solutions were equilibrated with a gas mixture of 97% 
oxygen and 3% carbon dioxide. Left ventricular pressure 
(LVP) was measured isovolumetrically with a transducer 
(DTX; Spectramed, Oxnard, Calif.) connected to a flexi- 
ble, saline solution-filled latex balloon (Hugo Sachs Elec- 
tronik, KG, March-Hugstetten, Germany) inserted into 
the left ventricle through the mitral valve by way of acnt 
in the left atrium. Balloon volume was adjusted to main- 
tain an end-diastolic LVP of 6 mm Hg. Positive and 
negative maximum instantaneous pressure changes (dP/ 
dtmax) were determined electronically with an analog 
differentiator. 
Electrograms were recorded with pairs of bipolar elec- 
trodes (plastic-coated silver, diameter 125/xm) placed on 
the right atrial appendage and on the right ventricular 
pulmonary conus. The electrode signals were amplified 
and displayed continuously on a digital oscilloscope 
(Nicolet 310; Nicolet Instrument Corporation, Madison, 
Wis.) and audially monitored. Electrogram intervals for 
determination of heart rate and atrioventricular conduc- 
tion time were measured on-line by digital timer systems 
that allowed instantaneous interval and rate analyses. 
Ventricular tachycardia was defined by the presence of 
uniform or multiform ventricular waveforms and laster 
ventricular than atrial rate. Ventricular fibrillation was 
defined by the presence of erratic activity in the ventric- 
ular electrogram and by the absence of pressure genera- 
tion by the left ventricle. 
Coronary flow was measured on-line with an ultrasonic 
flow probe (Tl06 small animal blood flowmeter; Tran- 
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sonic Systems, Inc., Ithaca, N.Y.). Coronary sinus effluent 
was collected by a cannula placed in the right ventricle 
through the pulmonary artery after ligature of the venae 
cavae. Coronary outflow oxygen tension (Po a was mea- 
sured continuously on-line (Instech 203B; Instech Labo- 
ratories, Plymouth Meeting, Pa.). The temperature-con- 
trolled Clark electrode was recalibrated periodically by 
means of a bypass circuit with perfusate gassed with room 
air. Both inftow and outflow P% were verified off-line with 
a self-calibrating analyzer system (ABL-300; Radiometer, 
Copenhagen, Denmark). Oxygen delivery was calculated 
from the inltow Po2 times oxygen solubility (24 tzl/ml 
saline solution/760 mm Hg) times coronary flow per gram 
dry heart tissue weight. Myocardial oxygen consumption 
(MVO2) was calculated as follows: oxygen solubility times 
coronary flow per gram times the difference between 
inflow and outflow Po 2. Percentage of oxygen extraction 
was calculated as 100 times the dißerence between inflow 
and outflow Po2 divided by inflow Pos. ENciency of 
o y.¢gen utilization in performing contractile work was 
defined as systolic LVP times heart rate divided by MVO 2. 
~ I  directly measured electronic signals were displayed 
on 2' high-resolution elght-channel recorder (Astro-Med 
Dash 8; Astro-Med Inc., West Warwick, R.I.), tape- 
recorded for back-up (Vetter D 1; Vetter Co., Rebersburg, 
Pa.), and stored on ftoppy discs by a personal computer 
(model 310; Hewlett-Packard Co., Palo Alto, Calif.) 
equipped with a 12-bit analog-to-digital converter sam- 
pling at 10 Hz (AD 200; Infotek Systems, Anaheim, 
C~lif.). Each value is the mean of a 10-second data 
segment that was visually inspected to ensure absence of 
artifacts. 
The time constant of isovolumic pressure decline, ~-, 
which reflects the time required for LVP to fall about one 
third of its value at peak -dP/dt . . . .  was calculated as 
described previously. 13 Peak -dP/dtma x was used as zero 
time, and pressure was recorded for 60 msec per beat for 
3 to 4 consecutive beats. The natural og of pressure at 
time t (ln Pt) was plotted against the t-axis, and ~-was 
defined as the negative reciprocal of the slope of the linear 
section of the curve, according to the equation in Pt = 
-t/T + In Po, where Pt is LVP at time t and Po is LVP at 
peak -dP/dt. This method has been successfully applied 
to the Langendorff-perfused guinea pig heart by using a 
fluid-filled left ventricular balloon system connected to a 
pressure transducer by a short tube of stift polyethylene 
material. TM 
Protocol and statistical analysis. After completion of 
the preparation and a 10-minute period of stabilization, 
adenosine (0.2 ml of a 2 mmol/L stock solution) was 
injected to det~gmine maximal coronary reserve. Only 
hearts that increased flow by 100% or more were in- 
cluded. After 30 minutes of further stabilization, baseline 
values of all measured variables were obtained and hearts 
were assigned to one of four groups: control (n = 10), 
HKR (n = 10), HKR with 1 mmol/L adenosine 
(HKR+A1, n = 10), and HKR with 5 mmol/L adenosine 
(HKR+A5, n = 10). 
Cardioplegic arrest was induced in all hearts by perfus- 
ing oxygenated cardioplegic Krebs solution for 5 minutes 
at room temperature (23 ° C). The left ventricular balloon 
was then deflated, and hearts remained unperfused and 
submerged in the same cardioplegic Krebs solution at 
room temperature for 3.5 hours. Control hearts were then 
reperfused with regular 37 ° C Krebs solution for 90 min- 
utes. Hearts in the HKR group were initially reperfused 
with 37 ° C oxygenated cardioplegic Krebs solution for 5 
minutes before reperfusion with regular Krebs solution. In 
hearts in the HKR+A1 and HKR+A5 groups, 1 and 5 
mmol/L adenosine, respectively, were added to the car- 
dioplegic Krebs solution during the initial 5 minutes of 
reperfusion only. The left ventricular balloon was rein- 
flated to 6 mm Hg end-diastolic pressure at 15 minutes of 
reperfusion, and all hearts were bolus-infused with lido- 
caine (0.05 ml of a 1% solution) at 20 minutes of 
reperfusion to convert any hearts not already in sinus 
rhythm. Subsequently, lidocaine was only given to those 
hearts that reverted to ventricular fibrillation. Coronary 
flow was measured uring induction of cardioplegia, dur- 
ing hyperkalemic reperfusion, and at 1, 2, 3, 4, 5, 15, 30, 
and 60 minutes of reperfusion. Measurements of all other 
variables were made at 30 and 60 minutes of reperfusion. 
Before and after ischemia and reperfusion, coronary 
reserve (adenosine bolus, 2 mmol/L) and responses to 
acetylcholine (1 tzmol/L) and nitroprusside (100/xmol/L) 
perfusion were assessed. Before ischemia nd at 10 and 00 
minutes of reperfusion, coronary effluent was collected 
and immediately frozen at -70 ° C for later analysis of 
adenosine and inosine levels by high-pressure liquid chro- 
matography. 15 
All data are expressed as mean +- standard error of the 
mean. Statistical differences among groups were obtained 
by two-way analysis of variance for repeated measure- 
ments (SuperANOVA; Abacus Concepts Inc., Berkeley, 
Calif.). Differences were considered significant at p < 
0.05. 
Results 
Coronary flow. Baseline coronary flow, measured 
in milliliters per minute, and dry tissue weight, 
measured in grams, did not differ among groups 
(Fig. 1). In all groups, flow remained essentially 
unchanged uring induction of cardioplegic arrest• 
In control hearts, peak reflow within 1 minute of 
reperfusion reached 85% _+ 8% of 52 +_ 2 tal/ 
min/gin preischemic flow and stabilized at 57% +_ 
4% after 3 minutes. In hearts in the HKR group, 
peak reflow was 93% _+ 7% of 58 +_ 3 ml/min/gm 
preischemic flow but stabilized at 45% _+ 3% until 
the end of the 5-minute hyperkalemic reperfusion. 
During perfusion with regular Krebs solution, coro- 
nary flow reached 58% + 2% of baseline within 5 
minutes and remained at this level until 60 rninutes 
of reperfusion. In hearts in the HKR+A1 group, in 
which 1 mmol/L adenosine was present during the 5 
minutes of HKR,  peak reflow slightly exceeded 
preischemic baseline flow (112% _+ 7% of 57 _+ 3 
ml/min/gm basal flow). At the end of HKR,  flow had 
stabilized at 79% + 3% of the preischemic value. 
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Fig. 1. The time course of coronary flow (in milliliters per minute per gram dry weight) is illustrated for 
four groups: control, HKR, HKR+A1, and HKR+A5. Measurements were taken before ischemia nd 
reperfusion at baseline (BL) and at the end of 5 minutes of perfusion with cardioplegic Krebs solution 
(CP). After 210 minutes of ischemia (ISCH), further measurements were obtained at peak reflow (PRF), 
the end of the 5 minutes of initial HKR, and after 1, 2, 3, 4, 5, 15, 30, and 60 minutes of reperfusion after 
the start of perfusion with regular Krebs solution. For better identification ofsingle data points, the initial 
15 minutes of reperfusion were stretched on the x-axis scale. Means _+ standard error of the mean. Symbols 
indica~e p values: *, p < 0.05 vs control; #, p < 0.05 vs HKR; $, p < 0.05 vs HKR+A1. 
Subsequently, flow slowly decreased to 76% _+ 5% 
and 65% -+ 3% at 15 and 30 minutes, respectively, 
but did not change thereafter (64% + 3% at 60 
minutes). Reperfusion with 5 mmol/L adenosine in 
hyperkalemic Krebs solution did not further in- 
crease peak reflow (123% _+ 9% of the 60 -+ 2 
ml/min/gm baseline flow), nor did it affect steady- 
state perfusion at the end of HKR (83% _+ 5% of 
initial flow). In contrast o hearts in the HKR+A1 
group, however, coronary flow did not decrease 
during perfusion with regular Krebs solution with- 
out adenosine and it remained significantly less 
depressed (83% _+ 5% and 81% _+ 6% at 30 and 60 
minutes, respectively) compared with flows in all 
other groups. 
Heart rate and cardiac rhythm. Baseline heart 
rate was about 230 beats/min in all four groups and 
increased !slightly (by 5% to 20%) on reperfusion. 
There were no differences among groups. Most of 
the hearts!were dysrhythmic or fibrillated on reper- 
fusion. After 60 minutes, only 20% of control hearts 
but more ihan 50% of the hearts treated with HKR 
performed at stäble sinus rhythm, defined as fewer 
than five ventricular extrasystoles or periods of 
ventricular tachycardia per minute. In all hearts, 
hemodynamic and metabolic measurements were 
obtained uring periods of sinus rhythm. 
Left ventricular systolie and diastolic functions. 
Left ventricular contractile function was assessed by 
measuring isovolumetric LVP and dP/dtma ×. In this 
preparation, preload and afterload factors are held 
constant. In control hearts ischemic arrest and 60 
minutes of reperfusion decreased developed (sys- 
tolic minus diastolic) LVP (LVDP) and dP/dtma x to 
39% -+ 3% and 45% _+ 3% of preischemic values, 
respectively. HKR significantly improved both pa- 
rameters (LVDP 54% _+ 4%; dP/dtmax 62% -+ 5%). 
Addition of 1 mmol/L adenosine to the initial 
cardioplegic reperfusate had no additional effect on 
recovery of left ventricular contractile function. Ad- 
dition of 5 mmol/L adenosine to the cardioplegic 
reperfusate, however, further increased LVDP and 
dP/dtma x (60% -+ 4% and 78% _+ 8%, respectively; 
Fig. 2). Left ventricular diastolic function was as- 
sessed by determining -dP/dtma~, which reflects 
events that occur very early during LVP decline, and 
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Fig. 2. The baseline data and the data for 30 and 60 minutes of reperfusion are given for LVDP, +dP/dtma x 
(+dP/dt), -dP/dt .... (-dP/dt), and z (Tau). Left ventricular systolic and diastolic functions were markedly 
depressed after ischemia nd reperfusion. Recovery of left ventricular function was improved by HKR alone 
and was further enhanced by addition of adenosine to the initial cardioplegic reperfusate. Means _+ standard 
error of the mean. Symbols indicate p values: *, p < 0.05 vs control; #, p < 0.05 vs control and HKR. 
by determining r, which represents later events in 
the course of isovolumetric LVP decrease. In con- 
trol hearts, -dP/dtma ~decreased to 35% _+ 3% of 
-1483 +- 70 mm Hg/sec before cardioplegic arrest. 
HKR improved -dP/dtma x throughout the reperfu- 
sion period (52% + 5% of the preischemic values at 
60 minutes). Addition of 1 or 5 mmol/L adenosine 
had no significant effect on recovery of -dP/dtma x.
The r value increased to 149% +_ 5% of baseline in 
control hearts after 60 minutes of reperfusion and 
did not statistically differ in hearts in either HKR or 
HKR+A1 groups. Only the high concentration of 
adenosine in HKR+A5 hearts significantly reduced 
the time constant of relaxation, to 116% +_ 5% of 
baseline (Fig. 2). 
Oxygen metabolism. MVO2 decreased to 60% _+ 
3% of baseline after 60 minutes of reperfusion in 
control hearts but was maintained significantly bet- 
ter in hearts in the HKR (81% _+ 5%), HKR+A1 
(80% _+ 3%) and HKR+A5 (89% + 8%) groups 
The Journal oi' Thoracic and 
Cardiovascular Surgery 
Volume 111, Number  1 
Habazettl et al. 7 9 
700 
600 
r -~ 5OO D'l 
2lZ 
E 400 
E 
a__J 
300 
0 
< 200 
100 
BL 30 60 
7o _c: 
60 
b 
"ID 
50  
C .-- 
E 40 
L~ 30  
O 
ra_ 2O 
b 
c~ 10  
c 
O 
O o 0 
BL 30 60 
1000 - 
x: I t~ 800 - -  I 
b 
B 600 
, -  
E 
400 - 
o4 
0 200  - 
> 
BL 50 6O 
35 
I 
30 
%" 25 
œ 
D 
~--~ 20  
o \ 
c 15 © 
"õ ,5 
~-  10  \ 
5 ,I 
\ 
0 
BL 
\ 
< I 
50 60 
~- -}  Control ~ HKR ~ HKR+A1 ~ HKR+A5 
Fig. 3. The baseline data and the data at 30 and 60 minutes of reperfusion are given for the arterial to 
coronary venous oxygen difference (AVDoJ, coronary flow, MVO2, and the etficiency of oxygen utilization 
(elficiency). In control hearts, coronary flow was depressed to a degree similar to that of MVO2, suggesting an 
essentia]ly intact oxygen balance. HKR increased MVO 2 with no elfect on flow, resulting in an increased oxygen 
extraction (A VDo 9. Addition of 5 mmol/L adenosine to the initial reperfusate increased flow and reduced 
AVDo s to nearly baseline values. Elficiency remained equivalently depressed in all groups. Means _+ standard 
error of the mean. Symbols indicatep values: *,p < 0.05 vs control; #,p < 0.05 vs control, HKR, and HKR+A1. 
(Fig. 3). Arterial-venous oxygen difference, which in 
this preparation with constant arterial Po  2 also 
reflects oxygen extraction, increased in all groups 
but was significantly higher in hearts in the HKR 
group (133% _+ 7%) than in control hearts (111% _+ 
3%) or hearts in the HKR+A5 group (116% _+ 7%; 
Fig. 3). The: efficiency of the myocardium in convert- 
ing consumed oxygen into mechanical work was 
equally decreased in all groups, to about 75% of 
baseline (Fig. 3), 
Coronary reserve and vascular function. Before 
ischemia and reperfusion, coronary reserve, as eval- 
uated by bolus injection of adenosine, amounted to 
well above 100% of baseline flow in all groups. After 
ischemia and reperfusion, coronary reserve was 
equally depressed in all groups, to only a 30% 
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Fig. 4. Flow responses to coronary vasodilators before and after cardioplegic arrest and reperfusion. C1 
through C5, Resting flow immediately before the respective asodilator stimulation;ADE, 2 mmol/L adenosine 
bolus; ACH-M, maximal f ow response to acetylcholine infusion (1 txmol/L); ACH-P, steady-state flow during 
acetylcholine infusion and pacing the heart at the rate before infusion of the vasodilator; NP, nitroprusside (100 
~mol/L); BL, baseline; 30 and 60, respective periods of repeffusion i  minutes; ISCIt, ischemia (210-minute 
period). The increased postischemic basal flow in the HKR+A5 group did not result in improved responses to
the vasodilators. Means + standard error of the mean. All stimulations caused statistically significant flow 
increases; all postischemic responses were significantly less pronounced than respective preischemic responses. 
increase above the depressed postischemic resting 
flow. Postischemic flow responses to perfusion with 
n{troprusside and acetylcholine were similarly de- 
pressed in all groups (Fig. 4). The increased post- 
ischemic resting flow in hearts in the HKR+A5 
group had no effect on the respective flow re- 
Sponses. 
Adenosine and inosine levels. Because adenosine 
and inosine concentrations were not determined in 
all experiments, data from hearts in the control and 
HKR groups, which did not differ between groups, 
were pooled for analysis. As shown in Fig. 5, inosine 
concentrations increased ramatically on reperfu- 
sion but approached baseline values after 60 min- 
utes of reperfusion in all groups. Adenosine in 
coronary effluent increased only slightly in hearts in 
the control, HKR, and HKR+A1 groups at 10 
minutes of reperfusion. The pronounced increase of 
adenosine in the HKR+A5 group, to almost 2000 
nmol/L, mainly reflects the results of a single exper- 
iment in which adenosine increased from 2 to 9350 
nmol/L. This is in contrast o more moderate in- 
creases from 18 to 405 nmol/L in the remaining 
hearts in the HKR+A5 group. At 60 minutes of 
reperfusion, adenosine levels were significantly ele- 
vated only in hearts in the HKR+A5 group. 
Discussion 
We used a model of cardioplegic arrest and 
reperfusion i  isolated perfused guinea pig hearts to 
demonstrate he following: (1) Compared with nor- 
mal Krebs solution reperfusion, HKR improved 
recovery of myocardial function but not of coronary 
flow. (2) Addition of 5 mmol/L adenosine during 
only the initial 5 minutes of hyperkalemic reperfu- 
sion significantly increased coronary flow and addi- 
tionally enhanced myocardial function for up to 60 
minutes of reperfusion. (3) The postischemic eoro- 
nary flow responses to both endothelium-dependent 
and endothelium-independent vasodilators were 
similarly depressed in all groups. 
The finding of improved myocardial fun¢tion af- 
ter HKR confirms the results of Follette and co- 
workers,1, 2who first described the beneficial effects of 
warm cardioplegic blood reperfusion i dogs. Because 
this group added potassium to the reperfusate without 
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Fig. 5. Adenosine and inosine levels in coronary etltuent at baseline before ischemia (BL) and at 10 
minutes and 60 minutes of reperfusion. Data did not differ between control (C) and HKR groups and were 
therefore pooled for statistical analyses. Inosine concentrations increased similarly in all groups at 10 
minutes of reperfusion. Ischemia nd reperfusion caused amoderate increase in the release of endogenous 
adenosine from control and HKR hearts groups at 10 minutes of reperfusion. Both concentrations of 
ade•osine during initial HKR increased eNuent adenosine l vels after 10 minutes of reperfusion, but after 
60 minutes of reperfusion adenosine r mained elevated only in the HKR+A5 group. Control, n = 3; HKR, 
n = 2; HKR+A1, n = 5; HKR+A5, n = 5. Means + standard error of the mean. Symbols indicatep values: 
*, p < 0.05 vs BL; #, p < 0.05 vs C and HKR; $, p < 0.05 vs HKR+A1. 
adjusting osmolarity to normal, it is not entirely clear 
whether the observed beneficial effect of warm car- 
dioplegic blood reperfusion was caused by cardioplegic 
arrest or rather by hyperosmolarity. In our isolated 
heart study I the osmolarity of the cardioplegic Krebs 
solution was adjusted to 300 mosm by reducing sodium 
chloride in exchange for the increase in potassium 
chloride. Improved LVDP, dP/dtma~, and -dP/dtm~ 
after HKR treatment clearly indicate that myocardial 
systolic and diastolic functions are both better pre- 
served solely by HKR. Moreover, markedly improved 
myocardial Nnction was achieved without he antioxi- 
dative capacity of whole blood, as in warm cardioplegic 
blood repe~fusion, 4' 6,16 and also without pharmaco- 
logic free-radical scavengers. In our study, improved 
myocardial reoovery with HKR is probably caused by 
reduced oxygen demand uring initial reperfusion. At 
37 ° C, oxygen demand of the arrested and decom- 
pressed heart is reduced by 80% compared with the 
beating or fibrillating heart. 16 Reduced demand may 
allow myocardial tissue to use the redelivered oxygen 
more efficiently for processes not associated with the 
output of mechanical work. 6 
If the improved oxygen balance is indeed crucial 
for the beneficial effects of HKR, then the well- 
known vasoconstricting effect of elevated potassium 
chloride during HKR might limit t.he effectiveness of 
this therapy. Indeed, after ischemia nd reperfusion, 
coronary flow during HKR without adenosine de- 
creased to 45% + 3% of its preischemic baseline. 
The increased arterial-venous oxygen difference un- 
til 60 minutes of reperfusion in hearts in the HKR 
group demonstrates inadequate myocardial perfu- 
sion for oxygen demand and may indicate either 
more pronounced vascular damage (decreased oxy- 
gen delivery) or increased oxygen demand as a result 
of the enhanced metabolic demand. 
These data allow two conclusions: (1) Because 
hyperkalemia reduces the coronary vascular conduc- 
tance during and for several minutes after HKR, 
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oxygen delivery to the myocardium is limited during 
HKR. (2) HKR may not have aggravated damage to 
the coronary vasculature, but rather may have in- 
creased the metabolic demand as function im- 
proved. 
In previous experimental studies coronary flow dur- 
ing warm cardioplegic reperfusion was not well docu- 
mented, and clinical studies investigating coronary 
vascular resistance during cardioplegic reperfusion re- 
main inconclusive. 8' 9 We believe that if HKR did not 
limit oxygen supply, myocardial performance could be 
further improved. Various experimental studies have 
shown that vasodilators improve postischemic coro- 
nary ftow and myocardial function well beyond the 
period of drug infusion. TM 17-19 
Among the various cardiac effects of adenosine, 2°
the adenosine2 receptor-mediated increase in vas- 
cular conductance and oxygen delivery may be the 
pivotal mechanism during reperfusion. TM 17, 18, 21 
The two tested concentrations of adenosine, i mmol/L 
and 5 mmol/L, have been successfully used during 
hyperkalemic cardioplegic arrest, z2'23 In our study, 
both concentrations (administered during HKR only) 
increased flow during initial HKR, but only 5 mmol/L 
adenosine resulted in sustained enhancement of coro- 
nary flow and myocardial function during the entire 
reperfusion period. Improvements in initial flow and 
oxygen delivery during initial reperfusion, which were 
equivalent for both adenosine concentrations, cannot 
be the pivotal mechanism of the sustained effects of 5 
mmol/L adenosine. 
We can only speculate on the mechanisms of the 
beneficial effects of 5 mmol/L adenosine. Our data 
(Fig. 5) indicate that effective concentrations of 
adenosine were present in the myocardial tissue 
of hearts in the HKR+A5 group at 60 minutes of 
reperfusion. The subsequent vasodilation may have 
increased oxygen delivery and allowed better myo- 
cardial performance without affecting the mecha- 
nisms responsible for the depression of cardiac 
efficiency in converting oxygen to mechanical work. 
In a previous tudy from our laboratory, 15washout 
of endogenously produced adenosine after ischemia 
and reperfusion in isolated hearts persisted for 
longer than 10 minutes but was complete after 40 
minutes of reperfusion. This correlates well with out 
inosine and adenosine levels in the control, HKR, 
and HKR+A1 groups, but it does not explain the 
elevated adenosine levels in HKR+A5 hearts after 
60 minutes of reperfusion. The coronary vascular 
endothelium has a high metabolic rate for adeno- 
sine, 24 which may explain why 5 minutes of 5 
mmol/L but not 1 mmol/L adenosine reperfusion 
could load the myocardial tissue with sufficient 
adenosine to delay complete washout of the drug for 
more than 1 hour. According to an alternative 
hypothesis, during high-dose adenosine reperfusion 
in the presence of abundant oxygen and energy 
substrates, ome of the exogenously administered 
adenosine may be phosphorylated to produce aden- 
osine triphosphate (ATP) in excess of energy de- 
mand. 2» Such rapid ATP synthesis from exogenous 
adenosine was demonstrated in isolated cardiac 
muscle cells. 26 After washout of exogenous adeno- 
sine, these intracellular ATP stores might be de- 
phosphorylated to provide additional energy for 
enhanced cardiac function and release of adenosine 
for the observed flow increase. 
None of the treatments tested in our study had 
any effect on the attenuated coronary reserve re- 
sponse during reperfusion (Fig. 4). While a bolus 
injection of adenosine increased flow by about 120% 
to 150% before ischemia in all groups, flow in- 
creases were only 26% to 34% over postischemic 
resting flow. Because ndothelium-dependent (ace- 
tylcholine) and endothelium-independent (nitroprus- 
side) vasodilators elicited similar significant flow re- 
sponses, the postischemic depression of responses to 
both vasodilators indicates vascular smooth muscle 
damage rather than specific deterioration of endothe- 
lial function. 24 Possibly perivascular edema limited the 
flow responses after reperfusion. 
Although whole-animal experiments with blood 
as coronary perfusate are certainly rauch closer to 
the clinical setting, the isolated heart preparation 
allows control of preload and afterload factors, 
excludes neural and exocrine influences, and allows 
more precise on-line measurement of ventricular 
function indexes, coronary flow, and MVO» thus 
providing useful data. We conclude that HKR for 5 
minutes improves ubsequent myocardial function, 
probably by reducing oxygen demand for electrome- 
chanical work during early reperfusion. Increasing 
flow during HKR by administering up to 1 mmol/L 
adenosine provides no sustained additional benefits 
for either coronary flow or myocardial function. In 
contrast, 5 mmol/L adenosine during 5 minutes of 
HKR improves flow and myocardial function for up to 
60 minutes of reperfusion. Delayed washout of aden- 
osine or accelerated resynthesis of ATP during HKR 
and subsequent dephosphorylation, with consequent 
prolonged adenosinel receptor- and adenosin% re- 
ceptor-mediated ffects beyond the period of ade- 
nosine-enriched HKR, may account for the beneficial 
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effects of the higher dose of adenosine in our model. 
Although postischemic resting flow was improved in 
the HKR+A5 group after ischemia, the depression of 
coronary reserve was not affected by either HKR or 
adenosine. 
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